FDA Posts Drug-Safety Watch List
Posted on: Saturday, 6 September 2008, 00:00 CDT
The U.S. Food and Drug Administration has established a drug-safety watch list that will be posted quarterly on its Web site.
The agency said the list of drugs being evaluated for potential safety issues will be based on reports in its Adverse Event Reporting System.
"The appearance of a drug on this list does not mean that FDA has concluded that the drug has the listed risk, or that FDA has identified a causal relationship between the drug and the listed risk," the agency said Friday in a release. "It is on the list only because FDA has identified a potential safety issue."
Dr. Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, said patients should not stop taking a drug just because it appears on the list.
"My message to patients is this: Don't stop taking your medicine. If your doctor has prescribed a drug that appears on this list, you should continue taking it unless your doctor advises you differently," Woodcock said in a statement.
Source: United Press International
Related Articles
- Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
- Commenting on the U.S. Food and Drug Administration (FDA) Early Communication, Allergan Clarifies FDA's Inquiry Relates Primarily to High Dose Medical Uses of BOTOX(R), Rather Than BOTOX(R) Cosmetic for Aesthetic Use
- TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(K) Clearance of the AIGIS(Rx)(TM) Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacem
- Utah Senate Approves Preferred-Drug-List Bill, but Sponsor Criticizes Amendment
- TYZEKA(TM) (Telbivudine) Approved By U.S. Food and Drug Administration (FDA) As a New Treatment for Patients With Chronic Hepatitis B
- Chemical Heritage Foundation (CHF) and the Food and Drug Administration (FDA) Will Cosponsor FDA Centennial Conference at CHF on Tuesday, 16 May 2006
- Preferred Drug List is Rejected
- Preferred Drug List a Medicaid Option?
- U.S. Food and Drug Administration (FDA) Approves BARACLUDE(TM) (Entecavir) for Treatment of Chronic Hepatitis B
- National Drug List Expanded in Thailand
User Comments (0)
RSS Feeds